Cardiovascular magnetic resonance stress and rest T1-mapping using regadenoson for detection of ischemic heart disease compared to healthy controls
暂无分享,去创建一个
Iulia A. Popescu | S. Piechnik | S. Neubauer | Evan Hann | V. Ferreira | K. Chow | M. Burrage | M. Shanmuganathan | A. Masi | Qiang Zhang | R. Soundarajan | J. L. Pelado | E. Hann
[1] Stefan L. Zimmerman,et al. Quality assurance of quantitative cardiac T1-mapping in multicenter clinical trials – A T1 phantom program from the hypertrophic cardiomyopathy registry (HCMR) study , 2021, International journal of cardiology.
[2] R. Krittayaphong,et al. Clinical assessment of adenosine stress and rest cardiac magnetic resonance T1 mapping for detecting ischemic and infarcted myocardium , 2020, Scientific Reports.
[3] P. Kellman,et al. Females have higher myocardial perfusion, blood volume and extracellular volume compared to males – an adenosine stress cardiovascular magnetic resonance study , 2020, Scientific Reports.
[4] E. Nagel,et al. Standardized image interpretation and post-processing in cardiovascular magnetic resonance - 2020 update , 2020, Journal of Cardiovascular Magnetic Resonance.
[5] E. Nagel,et al. Standardized cardiovascular magnetic resonance imaging (CMR) protocols: 2020 update , 2020, Journal of Cardiovascular Magnetic Resonance.
[6] L. Ngo,et al. Changes in Myocardial Native T1 and T2 After Exercise Stress: A Noncontrast CMR Pilot Study. , 2020, JACC. Cardiovascular imaging.
[7] S. Piechnik,et al. Standardized image post-processing of cardiovascular magnetic resonance T1-mapping reduces variability and improves accuracy and consistency in myocardial tissue characterization. , 2020, International journal of cardiology.
[8] G. Campo,et al. Magnetic Resonance Perfusion or Fractional Flow Reserve in Coronary Disease. , 2019, The New England journal of medicine.
[9] Amit R. Patel,et al. Cardiac Magnetic Resonance Stress Perfusion Imaging for Evaluation of Patients With Chest Pain , 2019, Journal of the American College of Cardiology.
[10] R. Woodman,et al. Gadolinium-Free Cardiovascular Magnetic Resonance Stress T1 Mapping in Patients With Chronic Kidney Disease. , 2019, JACC. Cardiovascular imaging.
[11] M. Oudkerk,et al. T1 reactivity as an imaging biomarker in myocardial tissue characterization discriminating normal, ischemic and infarcted myocardium , 2019, The International Journal of Cardiovascular Imaging.
[12] G. Adam,et al. Stress T1-mapping cardiovascular magnetic resonance imaging and inducible myocardial ischemia , 2019, Clinical Research in Cardiology.
[13] J. Francis,et al. Adenosine stress CMR T1-mapping detects early microvascular dysfunction in patients with type 2 diabetes mellitus without obstructive coronary artery disease , 2017, Journal of Cardiovascular Magnetic Resonance.
[14] S. Piechnik,et al. State-of-the-art review: stress T1 mapping—technical considerations, pitfalls and emerging clinical applications , 2017, Magnetic Resonance Materials in Physics, Biology and Medicine.
[15] M. Robson,et al. Adenosine Stress and Rest T1 Mapping Can Differentiate Between Ischemic, Infarcted, Remote, and Normal Myocardium Without the Need for Gadolinium Contrast Agents , 2016, JACC. Cardiovascular imaging.
[16] J. Francis,et al. Adenosine stress native T1 mapping in severe aortic stenosis: evidence for a role of the intravascular compartment on myocardial T1 values , 2014, Journal of Cardiovascular Magnetic Resonance.
[17] M. Robson,et al. Native T1-mapping detects the location, extent and patterns of acute myocarditis without the need for gadolinium contrast agents , 2014, Journal of Cardiovascular Magnetic Resonance.
[18] Jane Nixon,et al. Comparison of Cardiovascular Magnetic Resonance and Single-Photon Emission Computed Tomography in Women With Suspected Coronary Artery Disease From the Clinical Evaluation of Magnetic Resonance Imaging in Coronary Heart Disease (CE-MARC) Trial , 2014, Circulation.
[19] A. Arai,et al. Safety and tolerability of regadenoson CMR , 2014, European heart journal cardiovascular Imaging.
[20] P. Kellman,et al. Regadenoson and adenosine are equivalent vasodilators and are superior than dipyridamole- a study of first pass quantitative perfusion cardiovascular magnetic resonance , 2013, Journal of Cardiovascular Magnetic Resonance.
[21] S. K. White,et al. Normal variation of magnetic resonance T1 relaxation times in the human population at 1.5 T using ShMOLLI , 2013, Journal of Cardiovascular Magnetic Resonance.
[22] M. Robson,et al. Non-contrast T1-mapping detects acute myocardial edema with high diagnostic accuracy: a comparison to T2-weighted cardiovascular magnetic resonance , 2012, Journal of Cardiovascular Magnetic Resonance.
[23] M. Robson,et al. Myocardial oxygenation in coronary artery disease: insights from blood oxygen level-dependent magnetic resonance imaging at 3 tesla. , 2012, Journal of the American College of Cardiology.
[24] S. Plein,et al. Cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary heart disease (CE-MARC): a prospective trial , 2012, The Lancet.
[25] Stefan Neubauer,et al. Shortened Modified Look-Locker Inversion recovery (ShMOLLI) for clinical myocardial T1-mapping at 1.5 and 3 T within a 9 heartbeat breathhold , 2010, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.
[26] Jie Zheng,et al. Roles of myocardial blood volume and flow in coronary artery disease: an experimental MRI study at rest and during hyperemia , 2010, European Radiology.
[27] R. Kerensky,et al. Regadenoson, a selective A2A adenosine receptor agonist, causes dose-dependent increases in coronary blood flow velocity in humans , 2007, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.
[28] S. Schoenberg,et al. Cardiac magnetic resonance perfusion imaging for the functional assessment of coronary artery disease: a comparison with coronary angiography and fractional flow reserve. , 2006, European heart journal.
[29] M. Ochoa,et al. Comparative Profile of Vasodilation by CVT-3146, a Novel A2A Receptor Agonist, and Adenosine in Conscious Dogs , 2003, Journal of Pharmacology and Experimental Therapeutics.
[30] S. Kaul,et al. Relation between myocardial oxygen consumption and myocardial blood volume: a study using myocardial contrast echocardiography. , 2002, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[31] I. Olivotto,et al. Effect of aging on myocardial perfusion reserve. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[32] R. Wilson,et al. Effects of adenosine on human coronary arterial circulation. , 1990, Circulation.